迈得医疗（688310）11月28日主力资金净买入1425.67万元

Core Viewpoint - As of November 28, 2025, Maide Medical (688310) closed at 16.03 yuan, down 4.53%, with a turnover rate of 4.12% and a trading volume of 68,500 hands, resulting in a transaction amount of 110 million yuan [1] Financial Performance - For the first three quarters of 2025, the company's main revenue was 225 million yuan, an increase of 2.31% year-on-year; the net profit attributable to the parent company was 8.84 million yuan, up 15.82% year-on-year; the non-recurring net profit was -1.28 million yuan, a decrease of 526.58% year-on-year [5] - In Q3 2025, the company's single-quarter main revenue was 83.64 million yuan, an increase of 54.38% year-on-year; the single-quarter net profit attributable to the parent company was 2.79 million yuan, up 224.07% year-on-year; the single-quarter non-recurring net profit was 1.24 million yuan, an increase of 118.23% year-on-year [5] Market Position and Ratios - Maide Medical's total market value is 2.665 billion yuan, with a net asset of 840 million yuan and a net profit of 8.84 million yuan [3] - The company's price-to-earnings ratio (P/E) is 226.15, while the industry average is 130.51; the price-to-book ratio (P/B) is 3.31, compared to the industry average of 4.59 [3] - The gross profit margin is 40.19%, significantly higher than the industry average of 27.79%, while the net profit margin is -2.43%, lower than the industry average of 4.37% [3] Capital Flow - On November 28, 2025, the net inflow of main funds was 14.26 million yuan, accounting for 13.01% of the total transaction amount; the net inflow of retail funds was 1.73 million yuan, accounting for 15.83% of the total transaction amount [1] - In terms of margin trading, the financing buy amounted to 19.92 million yuan, with a net buy of 12.48 million yuan, while there were no securities sold or repaid [2]